| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2025 ( Subtotal = $39,031,101 ) (Continued on the next page) |
| | 2025 | 2025 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | D43TW012481 | Digital Mobile Technologies to study Tuberculosis: A Multi-disciplinary Program | 001 | 3 | NIH | 12/29/2024 | $50,000 |
| | 2025 | 2025 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | D43TW012481 | Digital Mobile Technologies to study Tuberculosis: A Multi-disciplinary Program | 001 | 3 | NIH | 12/29/2024 | $190,876 |
| | 2025 | 2025 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R01HD110099 | The Role of the O-GlcNAc Modification in X-linked Intellectual Disability | 001 | 3 | NIH | 6/18/2025 | $37,071 |
| | 2025 | 2025 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R01HD110099 | The Role of the O-GlcNAc Modification in X-linked Intellectual Disability | 000 | 3 | NIH | 1/22/2025 | $333,642 |
| | 2025 | 2025 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | T1C54770 | Maternal and Child Health Public Health Catalyst Program | 00 | 1 | HRSA | 5/23/2025 | $135,000 |
| | 2025 | 2025 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R35GM148433 | O-glycosylation of cysteine-rich modules | 001 | 3 | NIH | 11/19/2024 | $394,110 |
| | 2025 | 2025 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R35GM150797 | Bacterial partners as a mode of fungal resistance to antimicrobial compounds | 000 | 3 | NIH | 5/7/2025 | $368,444 |
| | 2025 | 2025 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R01NS128096 | Mechanisms Driving Regenerative Neurogenesis in Planarians | 000 | 4 | NIH | 5/6/2025 | $377,500 |
| | 2025 | 2025 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R21DC022725 | Pinpoint the Sox10+ taste bud progenitor cells in von Ebner's glands and Sox10 regulation in cell differentiation | 000 | 1 | NIH | 5/16/2025 | $377,681 |
| | 2025 | 2025 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R01AI187028 | Increasing the protective capacity of antibodies by enhancing Fc-mediated responses | 000 | 1 | NIH | 5/7/2025 | $416,276 |
| | 2025 | 2025 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R01HD115812 | Using 2D and 3D adrenal gland tissues to investigate developmental and disease paradigms | 000 | 1 | NIH | 5/7/2025 | $718,499 |
| | 2025 | 2025 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R01AI168307 | Type-I Interferons drive cell-autonomous immunity to malaria | 001 | 4 | NIH | 6/13/2025 | $755,000 |
| | 2025 | 2025 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R01AI162989 | Targeted Pan-Antifungal Liposomes | 000 | 4 | NIH | 1/18/2025 | $516,754 |
| | 2025 | 2025 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R01NS124226 | The Role of KCa3.1 in Microglial function and in Parkinsons disease pathogenesis | 000 | 5 | NIH | 5/8/2025 | $382,212 |
| | 2025 | 2025 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R01AI163140 | Elucidating the Role of Endocytosis Via the Cytostome in the Life Cycle of Trypanosoma cruzi | 000 | 5 | NIH | 6/6/2025 | $479,817 |
| | 2025 | 2025 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R01NS128005 | Synaptic Dysfunction and Energy Failure in Parkinson's Disease | 000 | 4 | NIH | 4/8/2025 | $424,679 |
| | 2025 | 2025 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | T32GM145467 | T32 Predoctoral training grant in Glycosciences | 000 | 4 | NIH | 5/29/2025 | $321,270 |
| | 2025 | 2025 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | T32GM142623 | T32 Predoctoral Training Grant in Genetics | 000 | 4 | NIH | 6/11/2025 | $426,360 |
| | 2025 | 2025 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | U01AG074960 | Novel Reengineered Microbiome-based Biologic Therapy to Treat Cognitive and Behavioral Symptoms of Alzheimer's Disease and Related Dementias | 000 | 4 | NIH | 6/18/2025 | $1,441,664 |
| | 2025 | 2025 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R01GM144545 | Elucidating the Mechanistic Basis for Phagotrophy in the Protozoan Trypansoma cruzi | 000 | 4 | NIH | 4/30/2025 | $302,000 |
| | 2025 | 2025 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R35GM147510 | Contribution of Ligand Sets to Oxygen Activation in Iron-dependent Biocatalysts | 000 | 4 | NIH | 5/6/2025 | $377,500 |
| | 2025 | 2025 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R01AR078903 | Pathological Foundations of Skeletal Muscle After Volumetric Muscle Loss and Targets For Rehabilitation | 000 | 4 | NIH | 5/7/2025 | $441,721 |
| | 2025 | 2025 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R01NS121692 | Compensatory Mitochondrial Protective Mechanisms Against Oxidative Stress in PD | 000 | 4 | NIH | 6/9/2025 | $436,013 |
| | 2025 | 2025 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R01GM156837 | Evolution of Retrotransposon Control Mechanisms | 000 | 1 | NIH | 5/30/2025 | $372,263 |
| | 2025 | 2025 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R01AI174600 | Divergent Calcium Channels of the Apicomplexan parasite Toxoplasma gondii | 000 | 3 | NIH | 1/10/2025 | $582,006 |
| | 2025 | 2025 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R01NS119517 | Novel Modulators of TGFß1 signaling in regulation of remyelination by neural stem cells | 000 | 4 | NIH | 11/25/2024 | $335,675 |
| | 2025 | 2025 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R35GM143060 | Gene-Environment Interactions in Human Evolution and Complex Traits | 000 | 5 | NIH | 6/3/2025 | $377,500 |
| | 2025 | 2025 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R01CA252713 | Canine MHC-I genotyping and tumor specific neoantigen determination | 001 | 5 | NIH | 5/22/2025 | $45,960 |
| | 2025 | 2025 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R01CA252713 | Canine MHC-I genotyping and tumor specific neoantigen determination | 000 | 5 | NIH | 4/25/2025 | $413,651 |
| | 2025 | 2025 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R21AI182993 | Assessing the Mycobacterium tuberculosis carriage state | 000 | 1 | NIH | 4/21/2025 | $187,998 |
| | 2025 | 2025 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R01MH124803 | 5/5: Selective Antipsychotic Response to Clozapine in B-SNIP Biotype-1 (CLOZAPINE) | 000 | 5 | NIH | 5/1/2025 | $261,449 |
| | 2025 | 2025 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R35GM139656 | Unlocking sequence-structure-function-disease relationships in large protein super-families | 001 | 5 | NIH | 3/4/2025 | $415,854 |
| | 2025 | 2025 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R35GM139556 | Heterochromatin in the developing vertebrate embryo | 001 | 5 | NIH | 5/14/2025 | $377,500 |
| | 2025 | 2025 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R01AI185090 | Optimization of UltraPCR for detection of and assessment of treatment outcomes in Trypanosoma cruzi infection | 000 | 1 | NIH | 2/28/2025 | $504,703 |
| | 2025 | 2025 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R21AI183057 | The cystic fibrosis sputum compromises the ability of neutrophils to kill Staphylococcus aureus | 000 | 2 | NIH | 2/12/2025 | $217,125 |
| | 2025 | 2025 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R01HL172496 | Nitric Oxide Functionalized Antibiotics to Combat Infections and Thrombosis for Extracorporeal Life Support | 000 | 2 | NIH | 1/28/2025 | $440,366 |
| | 2025 | 2025 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R01GM111939 | Structure and Function in alpha-Dystroglycan Glycosylation | 000 | 11 | NIH | 1/8/2025 | $339,923 |
| | 2025 | 2025 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R35GM148240 | Platform for in vivo Metabolism | 001 | 3 | NIH | 3/24/2025 | $368,242 |
| | 2025 | 2025 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R21HL168507 | A deep learning-enhanced multiphysics and multiscale framework for predictive modeling of inflammation-induced thrombosis | 000 | 2 | NIH | 4/21/2025 | $171,215 |
| | 2025 | 2025 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R21NS135412 | Characterizing and treating peripheral nervous system dysfunction in Sanfilippo Syndrome | 000 | 1 | NIH | 1/27/2025 | $226,500 |
| | 2025 | 2025 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R01HL173931 | Metabolic control of human endothelial development via the COUP-TF/1-deoxysphingosine axis | 000 | 2 | NIH | 3/28/2025 | $511,305 |
| | 2025 | 2025 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R01AI173144 | Impacts of host lipid composition on antimicrobial susceptibilities of Staphylococcus aureus | 000 | 3 | NIH | 11/4/2024 | $471,568 |
| | 2025 | 2025 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R21HD112848 | Uterine epithelial ERα regulates preimplantation uterine immunity and sperm fitness | 000 | 2 | NIH | 5/30/2025 | $188,750 |
| | 2025 | 2025 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R01AI176776 | Synthesis and transport of outer membrane components across the Gram-negative cell envelope | 000 | 3 | NIH | 12/23/2024 | $640,850 |
| | 2025 | 2025 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R01DK133325 | Development and Standardization of a Novel Pituitary Adenoma Organoid Model for the Study and Treatment of Cushing's Disease | 004 | 4 | NIH | 5/7/2025 | $426,428 |
| | 2025 | 2025 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | F31AI181461 | Understanding Plasmodium falciparum's multidrug resistance protein through the characterization of a novel antimalarial class. | 000 | 2 | NIH | 5/7/2025 | $48,974 |
| | 2025 | 2025 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R01DA055630 | Early Adversity and Drug Use Vulnerability Among Low Income Rural Children: Testing a Neuro-ecological Model of Resilience | 002 | 3 | NIH | 4/9/2025 | $68,369 |
| | 2025 | 2025 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R01DA055630 | Early Adversity and Drug Use Vulnerability Among Low Income Rural Children: Testing a Neuro-ecological Model of Resilience | 001 | 3 | NIH | 1/22/2025 | $54,644 |
| | 2025 | 2025 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R01DA055630 | Early Adversity and Drug Use Vulnerability Among Low Income Rural Children: Testing a Neuro-ecological Model of Resilience | 000 | 3 | NIH | 1/17/2025 | $615,311 |
|
